Search results
Study investigates systemic thrombolysis in patients with liver cirrhosis
Medical Xpress· 1 day agoThe prevalence of Portal Vein Thrombosis (PVT) varies significantly at different stages of liver disease: 10% in compensated patients, 17% in decompensated patients, 9% in those with acute decompensated ...
8 Natural Treatments for Hepatitis C
Healthline· 5 days agoThere’s no clear evidence that natural treatments, such as herbs, vitamins, or certain foods, can help cure hepatitis C. However, some may support liver...
Update on the STING signaling pathway in developing nonalcoholic fatty liver disease
Medical Xpress· 1 day agoNonalcoholic fatty liver disease (NAFLD) has become the most prevalent chronic liver condition worldwide, affecting about 25% of the global population due to the increasing rates of obesity ...
Check Your Health- Utahns Over 18 Should be Tested for Hepatitis C at Least Once
KUTV Salt Lake City· 3 days agoMay is Hepatitis Awareness Month. Hepatitis C is a liver disease caused when someone is infected...
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Akero...
FOX 59 Indianapolis· 1 day agoFaruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Akero Therapeutics, Inc. ("Akero" or the "Company") (NASDAQ: AKRO) and reminds investors ...
Infected Blood Scandal: What are the symptoms and treatments for the deadly virus hepatitis?
The Independent via Yahoo News· 6 days agoBut most people infected as children develop a long-term infection. This is known as chronic...
How to Treat AUD in Patients With Liver Disease
Medscape· 6 days agoStatistics from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) show that from 2000 to 2019, deaths due to alcohol-associated liver ...
Gilead to Present Latest Research Across Key Liver Disease Indications at the European Association...
Morningstar· 3 days agoGilead Sciences, Inc. (Nasdaq:GILD) today announced new research to be presented at the European Association for the Study of the Liver (EASL) Congress, June 5-8, 2024 in Milan, Italy. To drive ...
Akero Therapeutics (AKRO) SYMMETRY Study Under Fire in Class Action – AKRO Investors with...
Morningstar· 5 days agoSAN FRANCISCO, May 20, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Akero Therapeutics, Inc. (NASDAQ: AKRO) investors who suffered substantial losses to submit their losses now. Class Period: Sep. 13, 2022 – Oct. 9, 2023Lead Plaintiff Deadline
Symptoms of Fatty Liver Disease in Females: What You Should Know
Healthline· 3 days agoThe risk of females developing fatty liver disease rises significantly after menopause. Learn more...